Stroke is a major cause of morbidity and mortality in Asia, and its pattern is changing. The incidence of haemorrhagic stroke is declining while the incidence of ischaemic stroke caused by large artery atherothromboembolism is increasing secondary to an increase in the prevalence of hypercholesterolemia. The Working Group on Stroke and Lipids Management in Asia Consensus Panel assembled leading experts from the region to reach a consensus on how to address this challenge. The group discussed the observational epidemiology of the relationship between cholesterol and risk of stroke, the clinical trial evidence base for cholesterol-lowering for stroke prevention, and issues specific to stroke and lipid management for Asian doctors and patients. Stroke guidelines from many of the Asian countries have recently recommended consideration of statins for recurrent stroke prevention in patients with previous ischaemic stroke or transient ischaemic attack. However, because these recommendations have yet to be
StrongKMathersCBonitaR. Preventing stroke: saving lives around the world. Lancet Neurol2007; 6:182–7.
2.
LiuMWuBWangWZLeeLMZhangSHKongLZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol2007; 6:456–64.
3.
ThammarojJSubramaniamVBhattacharyaJJ. Stroke in Asia. Neuroimaging Clin N Am2005; 15:273–82.
4.
ShinoharaY. Regional differences in incidence and management of stroke – is there any difference between Western and Japanese guidelines on antiplatelet therapy?Cerebrovasc Dis2006; 21 (Suppl. 1): 17–24.
5.
KhorGL. Cardiovascular epidemiology in the Asia-Pacific region. Asia Vac J Clin Nutr2001; 10:76–80.
6.
MorikawaYNakagawaHNaruseY. Trends in stroke incidence and acute case fatality in a Japanese rural area: the Oyabe study. Stroke2000; 31:1583–7.
7.
ZhaoDLiuJWangW. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino–MONICA–Beijing Project. Stroke2008; 39:1668–74.
8.
MorimotoKTakeshitaT. Relations between lifestyles and lifestyle-related diseases. Asian Med J2000; 43:460–9.
9.
KimYDChoiHYChoHJ. Increasing frequency and burden of cerebral artery atherosclerosis in Korean stroke patients. Yonsei Med J (in press).
10.
WoodwardMMartiniukA, Asia Pacific Cohort Studies Collaboration et al. Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischemic stroke in the Asia-Pacific region. Eur J Cardiovasc Prev Rehabil2008; 15:397–401.
11.
LewingtonSWhitlockG, Prospective Studies Collaboration et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet2007; 370:1829–39.
12.
Asia Pacific Cohort Studies Collaboration.Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol2003; 32:563–72.
13.
SuhIJeeSHKimHC. Low serum cholesterol and hemorrhagic stroke in men: Korea Medical Insurance Corporation Study. Lancet2001; 357:922–5.
14.
EbrahimSSungJSongYMFerrerRLLawlorDADavey SmithG. Serum cholesterol, haemorrhagic stroke, ischemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ2006; 333:22–5.
15.
WongLKGlobal burden of intracranial atherosclerosis. Int J Stroke2006; 1:158–9.
16.
SaccoRLKargmanDEGuQZamanilloMC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke1995; 26:14–20.
17.
WongKSNgPWTangA. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology2007; 68:2035–8.
18.
AmarencoPLabeurcheJ. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol2009; 8:453–63.
19.
AmarencoPLabreucheJLavalleePTouboulPJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke2004; 35:2902–9.
20.
Heart Protection Study Collaborative Group.Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet2004; 363:757–67.
21.
AmarencoPBogousslavskyJCallahanAIII. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med2006; 355:549–59.
22.
GoldsteinLBAmarencoP, SPARCL Investigators et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology2008; 70(Part 2): 2364–70.
23.
ChalelaJAKangDWWarachS. Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging2004; 14:54–7.
24.
LeeSHBaeHJYoonBWKimHKimDERohJK. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions. Stroke2002; 33:2845–9.
25.
NakamuraHArakawaK, MEGA Study Group et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet2006; 368:1155–63.
26.
YokoyamaMOrigasaHMatsuzakiMInvestigatorsJELIS. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet2007; 369:1090–8.
27.
TanakaKIshikawaY, JELIS Investigators et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke2008; 39:2052–8.
28.
MokVCLamWWChenXY. Statins for asymptomatic middle cerebral artery stenosis: the regression of cerebral artery stenosis study. Cerebrovasc Dis2009; 28:18–25.
29.
MokVCLamWWFanYH. Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol2009; 256:750–7.
Choi-KwonSKimJS. Lifestyle factors and risk of stroke in Seoul, Korea. J Stroke Cerebrovasc Dis1998; 7:414–20.
32.
Choi-KwonSYangTHKimEKJeonMYKimJS. Nutritional status in acute stroke: undernutrition versus overnutrition in different stroke subtypes. Acta Neurol Scand1998; 98:187–92.
33.
HeydenSHeymanAGoreeJA. Nonembolic occlusion of the middle cerebral and carotid arteries: a comparison of predisposing factors. Stroke1970; 1:363–9.
34.
KullerLReislerDM. An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am J Epidemiol1971; 93:1–9.
35.
CaplanLRGorelickPBHierDB. Race, sex and occlusive cerebrovascular disease: a review. Stroke1986; 17:648–55.
36.
LiaoJK. Safety and efficacy of statins in Asians. Am J Cardiol2007; 99:410–14.
37.
LeeGBaeHJKimJS. State of current lipid and hypertension treatment of stroke patients in Korea: The STROKE Study. Abstract presented at: 17th European Stroke Conference (ESC); 13–16 May 2008, Nice, France.
38.
KimJSYoonSS. Perspectives of stroke in persons living in Seoul, South Korea: a survey of 1000 subjects. Stroke1997; 28:1165–9.
39.
CrimminsDLalorE. Australasian Acute Stroke Guidelines. National Stroke Foundation, National Health and Medical Research Council (Australia), 2007.
40.
Chinese experts' suggestions for preventing ischemic stroke/TIA by statins. Chin J Intern Med2008; 47:873–5.
41.
Stroke Task Force Indonesian Neurological Association.Stroke Guidelines Indonesian Neurological Association, 2007.
42.
Clinical Practice Guideline for Stroke: Clinical Research Center for Stroke (led by Yoon BW). Guideline endorsement from the Korean Stroke Society, Korean Neurological Association and Korean Society for Geriatric Neurology, 2009. Available at http://www.stroke-crc.or.kr/popup_090513.html (accessed 16 September 2009)
43.
Malaysian Society of Neurosciences.Clinical Practice Guidelines: Management of Ischemic Stroke. Malaysia: Malaysian Society of Neurosciences, 2006. Available at http://www.neuro.org.my (accessed 16 September 2009).
44.
Stroke Society of the Philippines.Stroke Guidelines: Guidelines for the Prevention, Treatment and Rehabilitation of Brain Attack, 4th edn.Philippines: Stroke Society of the Philippines. Available at http://www.strokesocietyphil.org (accessed 16 September 2009).
Taiwan Stroke Society.Guideline of Management of Dyslipidemia in Stroke Patients. Taiwan: Taiwan Stroke Society. Available at http://www.stroke.org.tw/guideline/guideline_new.asp (accessed 16 September 2009).
47.
SithisukSKullavanichPChannarongN. Guideline for Primary Prevention of Atherosclerosis, 1st edn.Thailand, Sri-Mueng Printing Ltd, 2009.
48.
GrundySMCleemanJI, Merz CNB et al, for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation2004; 110:227–39.
49.
ShinoharaYYamaguchiT. Outline of the Japanese Guidelines for the Management of Stroke 2004 and subsequent revision. Int J Stroke2008; 3:55–62.
